Quick Answer
Zenas BioPharma, Inc. reported Total Assets of $383.64 million for the year ending 2025.
- Zenas BioPharma, Inc. showed an increase of +3.7% in Total Assets from 2024 to 2025.
- This data is from Zenas BioPharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2024: $403.43 million | Q1 2025: $333.77 million | Q2 2025: $293.09 million | Q3 2025: $322.02 million.
- Over the full 3 years of available data (2023 to 2025), Zenas BioPharma, Inc.'s Total Assets has grown by 462.7%.
- Historical annual values: Fiscal year 2025: $383.64 million | Fiscal year 2024: $369.97 million | Fiscal year 2023: $68.18 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: